New Lilly Study Reveals Underappreciation of Bowel Urgency as a Symptom of Ulcerative Colitis and Highlights Communication Gap Between Healthcare Providers and Patients

/PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) today announced results from the CONFIDE Study (Communicating Needs and Features of IBD Experiences) that...

Related Keywords

Germany ,Japan ,United States ,Canada ,Kitasato ,Japan General ,Melodie Narain Blackwell ,Davidt Rubin ,Stefan Schreiber ,Eli Lilly ,Simon Travis ,Remo Panaccione ,Kevin Hern ,Toshifumi Hibi ,Marla Dubinsky ,Marlo Scott ,Cem Kayhan ,Nuffield Department Of Medicine ,Kitasato Institute Hospital ,University Of Oxford ,Leonard Feinstein Inflammatory Bowel Disease Clinical Center ,University Of Calgary Cumming School Medicine ,Scientific Advisory Panel ,Exchange Commission ,Kitasato University ,University Of Chicago Medicine ,University Hospital Schleswig Holstein ,Communicating Needs ,Chicago Medicine ,Adelphi Real World ,Calgary Cumming School ,Internal Medicine ,Clinical Gastroenterology ,Nuffield Department ,Private Securities Litigation Reform Act ,United States Securities ,Eli Lilly And Company ,